Ruolan Han

University System of Ohio

H指数:9

被引数:1,060

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical characterization of ONM-412, an ultra-pH sensitive nanoparticle encapsulated IL-12 fusion protein

CANCER RESEARCH

IF16.6

2024-04-050

PRE

ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile

CANCER RESEARCH

IF16.6

2023-04-142

PRE

Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice

CANCER RESEARCH

IF16.6

2023-04-140

PRE

Improved tolerability and tumor specific delivery of a therapeutic bispecific T cell engager using a pH-sensitive nanoparticle platform

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

HAEMATOLOGICA

IF7.9

2020-09-1411

OAAI

Youssef, Youssef; Karkhanis, Vrajesh; Chan, Wing Keung; Jeney, Frankie; Canella, Alessandro; Zhang, Xiaoli; Sloan, Shelby; Prouty, Alexander; Helmig-Mason, Jobeth; Tsyba, Liudmyla; Hanel, Walter; Zheng, Xuguang; Zhang, Pu; Chung, Ji-Hyun; Lucas, David M.; Kauffman, Zachary; Larkin, Karilyn; Strohecker, Anne M.; Ozer, Hatice G.; Lapalombella, Rosa; Zhou, Hui; Xu-Monette, Zijun Y.; Young, Ken H.; Han, Ruolan; Nurmemmedov, Elmar; Nuovo, Gerard; Maddocks, Kami; Byrd, John C.; Baiocchi, Robert A.; Alinari, Lapo

In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinincal models: A report from the Pediatric Preclinical Testing Consortium (PPTC)

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2019-02-2174

OAAI

Tegavivint suppresses progression and metastasis of osteosarcoma via blockade of Wnt signaling/ALDH1 axis: Preclinical study of a novel Wnt/β-catenin pathway inhibitor

CANCER RESEARCH